Patents

US Patent 10,792,232. Methods to deliver antifibrinolytic drugs for anti-aging results. Filed Oct. 17, 2017.

PCT/US2018/026086. Methods to enhance a non-surgical medical treatment (anti-bruising). Filed April 4, 2018.

PCT/US18/46023. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Filed August 9, 2018.

PCT/US20/57877. Synergistic Combinations of Synthetic Lysine Analogs, Derivatives, or Mimetics and Pharmaceutical Agents for Enhanced Efficacy of the Pharmaceutical Agents. Filed October 29, 2020.

Multiple patents pending covering methods and compositions for use of lysine analogs and related agents against cancer, microbes, and aging conditions, among other things.

Trademarks

We claim trademark rights in the terms “Tranexamic Lysine”, “Tranexamic Arginine”, “Tranexamic Histidine”, and the “Tranexamic Class Antagonists”.

We also claim trademark rights in the acronyms “TXK”, “TXR”, “TXH”, and “TXCA”.

We claim trademark rights in the terms “Tranexamic Lysine”, “Tranexamic Arginine”, “Tranexamic Histidine”, and the “Tranexamic Class Antagonists”.

We also claim trademark rights in the acronyms “TXK”, “TXR”, “TXH”, and “TXCA”.